1. Product
Overview
1.1.
Market Definition
1.2.
Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for Study
1.2.3.
Key Market Segmentations
2. Research
Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validation
2.7. Assumptions
and Limitations
3. Executive
Summary
3.1.
Overview of the Market
3.2.
Overview of Key Market Segmentations
3.3.
Overview of Key Market Players
3.4.
Overview of Key Regions/Countries
3.5.
Overview of Market Drivers, Challenges, Trends
4. Voice
of Customer
5. Global
Peptide Therapeutics Market Outlook
5.1. Market
Size & Forecast
5.1.1.
By Value
5.2. Market
Share & Forecast
5.2.1.
By Application (Cancer,
Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Gastrointestinal
Disorders, Infectious Diseases, Pain, Dermatological Disorders, Neurological
Disorders, Renal Disorders, Others)
5.2.2.
By Type (Generic, Innovative)
5.2.3.
By Type of Manufacturers (In-house, Outsourced)
5.2.4.
By Route of Administration (Parenteral Route, Oral
Route, Pulmonary, Mucosal, Others)
5.2.5.
By Synthesis Technology (Solid Phase Peptide Synthesis
(SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology)
5.2.6.
By Region
5.2.7.
By Company (2023)
5.3. Market
Map
6. North
America Peptide Therapeutics Market Outlook
6.1. Market
Size & Forecast
6.1.1.
By Value
6.2. Market
Share & Forecast
6.2.1.
By Application
6.2.2.
By Type
6.2.3.
By Type of Manufacturers
6.2.4.
By Route of Administration
6.2.5.
By Synthesis Technology
6.2.6.
By Country
6.3. North
America: Country Analysis
6.3.1.
United States Peptide Therapeutics Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Application
6.3.1.2.2.
By Type
6.3.1.2.3.
By Type of Manufacturers
6.3.1.2.4.
By Route of Administration
6.3.1.2.5.
By Synthesis Technology
6.3.2.
Canada Peptide Therapeutics Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Application
6.3.2.2.2.
By Type
6.3.2.2.3.
By Type of Manufacturers
6.3.2.2.4.
By Route of Administration
6.3.2.2.5.
By Synthesis Technology
6.3.3.
Mexico Peptide Therapeutics Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Application
6.3.3.2.2.
By Type
6.3.3.2.3.
By Type of Manufacturers
6.3.3.2.4.
By Route of Administration
6.3.3.2.5.
By Synthesis Technology
7. Europe
Peptide Therapeutics Market Outlook
7.1. Market
Size & Forecast
7.1.1.
By Value
7.2. Market
Share & Forecast
7.2.1.
By Application
7.2.2.
By Type
7.2.3.
By Type of Manufacturers
7.2.4.
By Route of Administration
7.2.5.
By Synthesis Technology
7.2.6.
By Country
7.3. Europe:
Country Analysis
7.3.1.
France Peptide Therapeutics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Application
7.3.1.2.2.
By Type
7.3.1.2.3.
By Type of Manufacturers
7.3.1.2.4.
By Route of Administration
7.3.1.2.5.
By Synthesis Technology
7.3.2.
Germany Peptide Therapeutics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Application
7.3.2.2.2.
By Type
7.3.2.2.3.
By Type of Manufacturers
7.3.2.2.4.
By Route of Administration
7.3.2.2.5.
By Synthesis Technology
7.3.3.
United Kingdom Peptide Therapeutics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Application
7.3.3.2.2.
By Type
7.3.3.2.3.
By Type of Manufacturers
7.3.3.2.4.
By Route of Administration
7.3.3.2.5.
By Synthesis Technology e
7.3.4.
Italy Peptide Therapeutics Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Application
7.3.4.2.2.
By Type
7.3.4.2.3.
By Type of Manufacturers
7.3.4.2.4.
By Route of Administration
7.3.4.2.5.
By Synthesis Technology
7.3.5.
Spain Peptide Therapeutics Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Application
7.3.5.2.2.
By Type
7.3.5.2.3.
By Type of Manufacturers
7.3.5.2.4.
By Route of Administration
7.3.5.2.5.
By Synthesis Technology
8. Asia-Pacific
Peptide Therapeutics Market Outlook
8.1. Market
Size & Forecast
8.1.1.
By Value
8.2. Market
Share & Forecast
8.2.1.
By Application
8.2.2.
By Type
8.2.3.
By Type of Manufacturers
8.2.4.
By Route of Administration
8.2.5.
By Synthesis Technology
8.2.6.
By Country
8.3. Asia-Pacific:
Country Analysis
8.3.1.
China Peptide Therapeutics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Application
8.3.1.2.2.
By Type
8.3.1.2.3.
By Type of Manufacturers
8.3.1.2.4.
By Route of Administration
8.3.1.2.5.
By Synthesis Technology
8.3.2.
India Peptide Therapeutics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Application
8.3.2.2.2.
By Type
8.3.2.2.3.
By Type of Manufacturers
8.3.2.2.4.
By Route of Administration
8.3.2.2.5.
By Synthesis Technology
8.3.3.
South Korea Peptide Therapeutics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Application
8.3.3.2.2.
By Type
8.3.3.2.3.
By Type of Manufacturers
8.3.3.2.4.
By Route of Administration
8.3.3.2.5.
By Synthesis Technology
8.3.4.
Japan Peptide Therapeutics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Application
8.3.4.2.2.
By Type
8.3.4.2.3.
By Type of Manufacturers
8.3.4.2.4.
By Route of Administration
8.3.4.2.5.
By Synthesis Technology
8.3.5.
Australia Peptide Therapeutics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Application
8.3.5.2.2.
By Type
8.3.5.2.3.
By Type of Manufacturers
8.3.5.2.4.
By Route of Administration
8.3.5.2.5.
By Synthesis Technology
9. South
America Peptide Therapeutics Market Outlook
9.1. Market
Size & Forecast
9.1.1.
By Value
9.2. Market
Share & Forecast
9.2.1.
By Application
9.2.2.
By Type
9.2.3.
By Type of Manufacturers
9.2.4.
By Route of Administration
9.2.5.
By Synthesis Technology
9.2.6.
By Country
9.3. South
America: Country Analysis
9.3.1.
Brazil Peptide Therapeutics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Application
9.3.1.2.2.
By Type
9.3.1.2.3.
By Type of Manufacturers
9.3.1.2.4.
By Route of Administration
9.3.1.2.5.
By Synthesis Technology
9.3.2.
Argentina Peptide Therapeutics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Application
9.3.2.2.2.
By Type
9.3.2.2.3.
By Type of Manufacturers
9.3.2.2.4.
By Route of Administration
9.3.2.2.5.
By Synthesis Technology
9.3.3.
Colombia Peptide Therapeutics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Application
9.3.3.2.2.
By Type
9.3.3.2.3.
By Type of Manufacturers
9.3.3.2.4.
By Route of Administration
9.3.3.2.5.
By Synthesis Technology
10. Middle
East and Africa Peptide Therapeutics Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Application
10.2.2.
By Type
10.2.3.
By Type of Manufacturers
10.2.4.
By Route of Administration
10.2.5.
By Synthesis Technology
10.2.6.
By Country
10.3.
MEA: Country Analysis
10.3.1.
South Africa Peptide Therapeutics Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1.
By Application
10.3.1.2.2.
By Type
10.3.1.2.3.
By Type of Manufacturers
10.3.1.2.4.
By Route of Administration
10.3.1.2.5.
By Synthesis Technology
10.3.2.
Saudi Arabia Peptide Therapeutics Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1.
By Application
10.3.2.2.2.
By Type
10.3.2.2.3.
By Type of Manufacturers
10.3.2.2.4.
By Route of Administration
10.3.2.2.5.
By Synthesis Technology
10.3.3.
UAE Peptide Therapeutics Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1.
By Application
10.3.3.2.2.
By Type
10.3.3.2.3.
By Type of Manufacturers
10.3.3.2.4.
By Route of Administration
10.3.3.2.5.
By Synthesis Technology
10.3.4.
Kuwait Peptide Therapeutics Market Outlook
10.3.4.1. Market
Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market
Share & Forecast
10.3.4.2.1.
By Application
10.3.4.2.2.
By Type
10.3.4.2.3.
By Type of Manufacturers
10.3.4.2.4.
By Route of Administration
10.3.4.2.5.
By Synthesis Technology
11. Market
Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market
Trends & Developments
12.1.
Recent Developments
12.2.
Product Launches
12.3.
Mergers & Acquisitions
13. Porter’s
Five Forces Analysis
13.1.
Competition in the Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute Product
14. Competitive
Landscape
14.1.
Eli Lilly and Co.
14.1.1.
Business Overview
14.1.2.
Company Snapshot
14.1.3.
Products & Services
14.1.4.
Financials (As Reported)
14.1.5.
Recent Developments
14.1.6.
Key Personnel Details
14.1.7.
SWOT Analysis
14.2.
Pfizer Inc.
14.3.
Amgen Inc.
14.4.
Takeda Pharmaceutical Co Ltd.
14.5.
AstraZeneca Pharmaceuticals LP
14.6.
Teva Pharmaceutical Industries Ltd.
14.7.
Sanofi S.A.
14.8.
F Hoffmann-La Roche AG
14.9.
Novartis AG
14.10.
Novo Nordisk A/S
15. Strategic
Recommendations
16. About
Us & Disclaimer